ArticleToxicological research2025
SRXN1 is a novel protective factor against methylmercury-induced apoptosis in C17.2 mouse neural stem cells.
Article in Toxicological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Punicalagin Inhibits the Growth and Proliferation of Ovarian Epithelial Adenocarcinoma Cells Via Apoptosis and Autophagic Cell Death.Journal of biochemical and molecular toxicology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Methylmercury is an environmental pollutant that exhibits severe cerebral neurotoxicity and remains a worldwide problem. Motor and mental development disorders have been observed in children born to women who consumed relatively large amounts of methylmercury via contaminated fish during pregnancy. We previously found by RNA-sequencing analysis that treatment of C17.2 mouse neural stem cells with methylmercury induced the expression of SRXN1 (sulfiredoxin-1), a redox regulator. In this study, we examined the effect of methylmercury on SRXN1 expression and the role of SRXN1 in methylmercury-induced cell death. After C17.2 cells were treated with methylmercury, both mRNA and protein expression of SRXN1 increased in a time- and concentration-dependent manner. Because the induction of SRXN1 expression by methylmercury was suppressed by pretreatment with a transcription inhibitor, we searched the upstream region of the SRXN1 gene and found a binding sequence for transcription factor 3 (TCF3). Interestingly, the induction of SRXN1 expression by methylmercury was attenuated in cells in which TCF3 expression was suppressed by siRNA compared with control cells. This suggests that TCF3 is involved in the induction of SRXN1 expression by methylmercury. We previously reported that TCF3 overexpression suppressed methylmercury-induced apoptosis; in the present study, we found that SRXN1 overexpression also suppressed methylmercury-induced apoptosis, as assessed by cleaved caspase-3 expression. In summary, our results indicate that SRXN1 induced by TCF3-mediated expression is a novel protective factor against methylmercury-induced apoptosis. Supplementary Information: The online version contains supplementary material available at 10.1007/s43188-024-00277-6.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.